Conclusions
Currently, there are no standard guidelines for the timing of PPMI
following TAVR. The reviewed literature suggests a liberal use of PPMI
immediately after TAVR, since a temporary pacemaker and more extended
rhythm monitoring of all patients post-procedure can increase
hospitalization days and costs and delay rehabilitation (49). Novel
technology like Tempo pacemaker can be used safely for temporary pacing
in ambulating patients for up to 7 days post TAVR, and needs further
validation (51). Our meta-analysis identified 14 factors significantly
associated with increased risk of PPMI following TAVR. This suggests
that recognizing the high-risk population prior to performing TAVR, and
targeting the risk factors that are modifiable, can help reduce the rate
of PPMI.